# Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

> **NCT01979211** · PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 24 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Cetuximab
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01979211
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2022-01-19
- **Final completion:** 2022-01-19
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01979211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01979211, "Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01979211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*